Abstract:Key PointsEndocrine-disrupting chemicals (EDCs) might increase the risk of childhood neurodevelopmental disorders or obesity by disrupting hormone-mediated processes during critical periods of developmentThe developing fetus, infant and child might have enhanced sensitivity to environmental stressors such as EDCs and increased exposure to some EDCs due to developmentally appropriate behaviour, anatomy and physiologyThe available epidemiological evidence suggest that prenatal bisphenol A and phthalate exposure is associated with adverse neurobehavioural outcomes in children, but not excess adiposity or risk of obesity or being overweightEpidemiological studies show that prenatal PFAS exposure is associated with reduced fetal growth, excess adiposity and risk of being overweight or obese, but not neurobehavioural outcomesImproving EDC exposure measurement, reducing confounding bias, identifying discrete periods of vulnerability and sexually dimorphic associations, and quantifying the effects of EDC mixtures will enhance inferences made from epidemiological studies

Early-life exposure to EDCs: role in childhood obesity and neurodevelopment